Global shortage of two key treatments
Manx Care says there’s 'no immediate threat' to stroke patients, and those with heart conditions, due to a global shortage of two key treatments.
The Isle of Man, along with UK NHS trusts, is being asked to conserve supplies of two drugs - Alteplase and Tenecteplase - due to manufacturer issues.
The shortage is expected to last until early next year and hospitals are being asked to provide alternative treatments where appropriate.
Dr Sreeman Andole is the executive medical director, and stroke consultant, at Noble's Hospital:
RPU will be 'out in force' to stop drink and drug drivers
Ramsey Commissioners to spend more than £8k on deckchairs and storage unit
How to spot the signs of domestic and elder abuse this Christmas
Police appeal to parents after party of up to 50 young people 'becomes an issue'